Cytokinetics, Inc. Reports Fourth Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/27/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Cantor Fitzgerald Remains Bullish on Cytokinetics (CYTK)
February 17, 2017 7:50 AM ESTCantor Fitzgerald reiterated an Overweight rating and $21.00 price target on Cytokinetics (NASDAQ: CYTK). 4Q16 fully diluted EPS was $0.16, which was better than ($0.43) forecasts due to the inclusion of a $26 mln payment from Amgen for omecamtiv mecarbil.
Analyst Mara Goldstein commented, "We rate CYTK Overweight... More
FBR Capital Reiterates Outperform on Cytokinetics (CYTK) Following 4Q
February 17, 2017 7:17 AM ESTFBR Capital reiterated an Outperform rating and $24.00 price target on Cytokinetics (NASDAQ: CYTK) following the company's 4Q earnings report.
Analyst Vernon Bernardino commented, "On February 16, CYTK announced 4Q16 results dominated by the achievement of significant milestones in its cardiac muscle-directed clinical program... More
Piper Jaffray Reiterates Overweight Rating and $15 PT on Cytokinetics (CYTK) Following 4Q16 Results
February 17, 2017 6:05 AM ESTPiper Jaffray analyst Charles Duncan reiterates Overweight rating and $15 price target on Cytokinetics Inc. (NASDAQ: CYTK), suggesting the companys cash position provides strong 12 month upside potential, as 2016 fourth quarter results include $33 million in revenues and $156 million in year-end cash.
Duncan comments, "On Thursday AMC... More
